OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 50 filers reported holding OCUPHIRE PHARMA INC in Q4 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $292,695 | -36.0% | 191,304 | -15.9% | 0.58% | -31.6% |
| Q1 2024 | $457,197 | -39.9% | 227,461 | -10.0% | 0.85% | -36.1% |
| Q4 2023 | $760,835 | -38.3% | 252,769 | -31.3% | 1.33% | -42.7% |
| Q3 2023 | $1,232,812 | -16.9% | 368,003 | +7.6% | 2.32% | -3.6% |
| Q2 2023 | $1,483,671 | +16.2% | 341,860 | +0.4% | 2.40% | +11.5% |
| Q1 2023 | $1,276,976 | +10.0% | 340,526 | +3.5% | 2.16% | +32.2% |
| Q4 2022 | $1,161,264 | +81.2% | 328,970 | +2.7% | 1.63% | +128.3% |
| Q3 2022 | $641,000 | +7.4% | 320,332 | +3.0% | 0.71% | +16.9% |
| Q2 2022 | $597,000 | +48.1% | 311,120 | +149.8% | 0.61% | +97.1% |
| Q1 2022 | $403,000 | +45.5% | 124,544 | +67.4% | 0.31% | +55.8% |
| Q4 2021 | $277,000 | – | 74,420 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Richmond Brothers, Inc. | 311,120 | $597,000 | 0.61% |
| Diametric Capital, LP | 34,356 | $66,000 | 0.05% |
| Eidelman Virant Capital | 25,000 | $48,000 | 0.04% |
| RICE HALL JAMES & ASSOCIATES, LLC | 327,494 | $629,000 | 0.03% |
| Warberg Asset Management LLC | 24,200 | $46,000 | 0.01% |
| Stokes Family Office, LLC | 12,120 | $23,000 | 0.00% |
| Cornerstone Capital, Inc. | 13,857 | $27,000 | 0.00% |
| Frontier Wealth Management LLC | 18,000 | $35,000 | 0.00% |
| MCF Advisors LLC | 10,565 | $20,000 | 0.00% |
| CarsonAllaria Wealth Management, Ltd. | 1,000 | $2,000 | 0.00% |